Canada has approved a generic version of Ozempic, also known as semaglutide, which is expected to be cheaper than the original medication. This development is notable as it is not currently available in the US. The approval is seen as a significant move, with Canada being the first in the G7 to do so, and is viewed as a test case for the global market.